Tripeptide-3 is a well-known biomimetic peptide that functions as a topical neuromodulator. Its primary mechanism is to reduce the appearance of dynamic expression lines by interfering with the signal that causes facial muscle contraction, offering a "Botox-like" effect.
Presynaptic Neuromodulation: Tripeptide-3 acts at the presynaptic membrane of the neuromuscular junction. It is designed to mimic the C-terminal end of the SNAP-25 protein, a key component of the SNARE complex, inhibiting excessive acetylcholine (ACh) release.
Reduction of Muscle Contraction: With less acetylcholine signaling, underlying facial muscles receive a reduced signal to contract, leading to a relaxation of micro-contractions and softening of dynamic wrinkles like crow's feet and forehead lines.
Non-Paralytic Action: This mechanism reduces but does not completely block muscle contraction, resulting in a natural-looking smoothing effect without the risk of a "frozen" appearance.
In a 28-day double-blind clinical study, Tripeptide-3 showed a statistically significant reduction in the depth and volume of wrinkles in the crow's feet area. Participants reported skin appeared "smoother," "less lined," and "more relaxed."

Tripeptide-3 has an excellent safety profile. It is non-irritating, non-sensitizing, and well-tolerated. As a topical cosmetic ingredient, it does not cause systemic effects or muscle paralysis.

Recommended Usage Level: 2% to 5% in the final formulation.
Target Applications:





